<DOC>
	<DOC>NCT01090531</DOC>
	<brief_summary>This observational long-term follow-up study will evaluate demographic, clinical, histological, biochemical, and virological parameters of patients with chronic hepatitis B and low viremia who do not require antiviral therapy according to current guidelines. Liver stiffness values as detected by FibroScan and ARFI will also be collected if available. All data will be collected at yearly intervals (minimum). Patients included in the study are followed for up to 10 years. The target sample size is &lt;1000.</brief_summary>
	<brief_title>Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Viremia</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>adult patient, age 1879 chronic hepatitis B HBVDNA &lt; 100.000 IU/ml ALT â‰¤2 x ULN recent liver histology and/or FibroScan measurement willingness to sign informed consent current or past antiviral therapy for hepatitis B chronic hepatitis B in immune tolerance phase (HBeAg positive, high viral load) coinfection with HIV, HCV malignant disease HCC or other liver tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>